VP-14637 is primarily utilized in research settings, particularly in the study of viral infections. It has shown potential as an inhibitor of respiratory syncytial virus (RSV), making it a candidate for antiviral drug development. Researchers explore its mechanism of action to understand how it can block viral replication, which could lead to the creation of effective treatments for RSV infections. Additionally, its properties are investigated for potential applications in other viral diseases, contributing to the broader field of antiviral therapeutics.